New DSM-5 category 'unspecified catatonia' is a boost for pediatric catatonia: Review and case reports

Dirk M. Dhossche, Michal Goetz, G. Gazdag, Pascal Sienaert

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

SUMMARY The creation in DSM-5 of a new category 'unspecified catatonia' aspires to improve diagnosis and treatment of catatonia in patients of all ages without diagnosable major psychotic, affective or medical disorders. Unspecified catatonia may be particularly beneficial in boosting recognition and treatment of pediatric catatonia that often occurs outside these disorders. Until now, pediatric catatonia has been poorly recognized. Benzodiazepines and electroconvulsive therapy are underutilized in pediatric catatonia, yet are safe and effective treatments without the risk of worsening catatonia or precipitating neuroleptic malignant syndrome. Unspecified catatonia should be considered when catatonic symptoms are present in children and adolescents with autistic and other developmental disorders, autoimmune encephalitides, tic disorders (with or without self-injury) and Tourette's syndrome, Kleine-Levin syndrome, post-traumatic reactions, pervasive refusal syndrome and other disorders. The aspirations of the 'unspecified catatonia' category to reduce morbidity and mortality and to increase further research are bound to be tested in the field of pediatric catatonia over the next few years. Changes in DSM-5 regarding the classification of catatonia are reviewed. Case reports are presented to illustrate the use of the new category, unspecified catatonia, in children and adolescents.

Original languageEnglish
Pages (from-to)401-410
Number of pages10
JournalNeuropsychiatry
Volume3
Issue number4
DOIs
Publication statusPublished - Aug 2013

Fingerprint

Catatonia
Pediatrics
Kleine-Levin Syndrome
Tic Disorders
Neuroleptic Malignant Syndrome
Tourette Syndrome
Electroconvulsive Therapy
Benzodiazepines

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

New DSM-5 category 'unspecified catatonia' is a boost for pediatric catatonia : Review and case reports. / Dhossche, Dirk M.; Goetz, Michal; Gazdag, G.; Sienaert, Pascal.

In: Neuropsychiatry, Vol. 3, No. 4, 08.2013, p. 401-410.

Research output: Contribution to journalArticle

Dhossche, Dirk M. ; Goetz, Michal ; Gazdag, G. ; Sienaert, Pascal. / New DSM-5 category 'unspecified catatonia' is a boost for pediatric catatonia : Review and case reports. In: Neuropsychiatry. 2013 ; Vol. 3, No. 4. pp. 401-410.
@article{9a1e18e7fc3544bfbece6504f94654d4,
title = "New DSM-5 category 'unspecified catatonia' is a boost for pediatric catatonia: Review and case reports",
abstract = "SUMMARY The creation in DSM-5 of a new category 'unspecified catatonia' aspires to improve diagnosis and treatment of catatonia in patients of all ages without diagnosable major psychotic, affective or medical disorders. Unspecified catatonia may be particularly beneficial in boosting recognition and treatment of pediatric catatonia that often occurs outside these disorders. Until now, pediatric catatonia has been poorly recognized. Benzodiazepines and electroconvulsive therapy are underutilized in pediatric catatonia, yet are safe and effective treatments without the risk of worsening catatonia or precipitating neuroleptic malignant syndrome. Unspecified catatonia should be considered when catatonic symptoms are present in children and adolescents with autistic and other developmental disorders, autoimmune encephalitides, tic disorders (with or without self-injury) and Tourette's syndrome, Kleine-Levin syndrome, post-traumatic reactions, pervasive refusal syndrome and other disorders. The aspirations of the 'unspecified catatonia' category to reduce morbidity and mortality and to increase further research are bound to be tested in the field of pediatric catatonia over the next few years. Changes in DSM-5 regarding the classification of catatonia are reviewed. Case reports are presented to illustrate the use of the new category, unspecified catatonia, in children and adolescents.",
author = "Dhossche, {Dirk M.} and Michal Goetz and G. Gazdag and Pascal Sienaert",
year = "2013",
month = "8",
doi = "10.2217/npy.13.42",
language = "English",
volume = "3",
pages = "401--410",
journal = "Neuropsychiatry",
issn = "1758-2008",
publisher = "University of Virginia",
number = "4",

}

TY - JOUR

T1 - New DSM-5 category 'unspecified catatonia' is a boost for pediatric catatonia

T2 - Review and case reports

AU - Dhossche, Dirk M.

AU - Goetz, Michal

AU - Gazdag, G.

AU - Sienaert, Pascal

PY - 2013/8

Y1 - 2013/8

N2 - SUMMARY The creation in DSM-5 of a new category 'unspecified catatonia' aspires to improve diagnosis and treatment of catatonia in patients of all ages without diagnosable major psychotic, affective or medical disorders. Unspecified catatonia may be particularly beneficial in boosting recognition and treatment of pediatric catatonia that often occurs outside these disorders. Until now, pediatric catatonia has been poorly recognized. Benzodiazepines and electroconvulsive therapy are underutilized in pediatric catatonia, yet are safe and effective treatments without the risk of worsening catatonia or precipitating neuroleptic malignant syndrome. Unspecified catatonia should be considered when catatonic symptoms are present in children and adolescents with autistic and other developmental disorders, autoimmune encephalitides, tic disorders (with or without self-injury) and Tourette's syndrome, Kleine-Levin syndrome, post-traumatic reactions, pervasive refusal syndrome and other disorders. The aspirations of the 'unspecified catatonia' category to reduce morbidity and mortality and to increase further research are bound to be tested in the field of pediatric catatonia over the next few years. Changes in DSM-5 regarding the classification of catatonia are reviewed. Case reports are presented to illustrate the use of the new category, unspecified catatonia, in children and adolescents.

AB - SUMMARY The creation in DSM-5 of a new category 'unspecified catatonia' aspires to improve diagnosis and treatment of catatonia in patients of all ages without diagnosable major psychotic, affective or medical disorders. Unspecified catatonia may be particularly beneficial in boosting recognition and treatment of pediatric catatonia that often occurs outside these disorders. Until now, pediatric catatonia has been poorly recognized. Benzodiazepines and electroconvulsive therapy are underutilized in pediatric catatonia, yet are safe and effective treatments without the risk of worsening catatonia or precipitating neuroleptic malignant syndrome. Unspecified catatonia should be considered when catatonic symptoms are present in children and adolescents with autistic and other developmental disorders, autoimmune encephalitides, tic disorders (with or without self-injury) and Tourette's syndrome, Kleine-Levin syndrome, post-traumatic reactions, pervasive refusal syndrome and other disorders. The aspirations of the 'unspecified catatonia' category to reduce morbidity and mortality and to increase further research are bound to be tested in the field of pediatric catatonia over the next few years. Changes in DSM-5 regarding the classification of catatonia are reviewed. Case reports are presented to illustrate the use of the new category, unspecified catatonia, in children and adolescents.

UR - http://www.scopus.com/inward/record.url?scp=84881405152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881405152&partnerID=8YFLogxK

U2 - 10.2217/npy.13.42

DO - 10.2217/npy.13.42

M3 - Article

AN - SCOPUS:84881405152

VL - 3

SP - 401

EP - 410

JO - Neuropsychiatry

JF - Neuropsychiatry

SN - 1758-2008

IS - 4

ER -